Alex Adjei
MD PhD
Chair, Department of Oncology
👥Biography 个人简介
Alex Adjei at Roswell Park has been a leading phase I oncology investigator, particularly in early development of MAPK pathway inhibitors and KRAS-targeted agents. His contributions to phase I methodology including combination dosing strategies and his leadership of early clinical trials for multiple approved oncology agents have been significant in the drug development field.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Alex Adjei 的研究动态
Follow Alex Adjei's research updates
留下邮箱，当我们发布与 Alex Adjei（Roswell Park Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment